November 05, 2019

Lumicell Initiates Pivotal Trial for Breast Cancer Surgical Guidance Solution

August 19, 2019

Lumicell Completes Enrollment of Phase C Feasibility Trial for Breast Cancer Surgical Guidance Solution

April 10, 2019

Feasibility Study Underway to Assess Lumicell Technology for Removing Ovarian and Peritoneal Cancer Tumors During the First Surgery

February 22, 2019

Lumicell Headquarters Expands Into New Boston-Area Office Space

September 18, 2018

Kevin Hershberger Joins Lumicell as Chief Financial Officer

August 15, 2018

Lumicell Expands Board with Addition of Michael Ruettgers

August 8, 2018

Lumicell Launches Wound Care Infection and Perfusion Division

July 18, 2018

Lumicell Forms Scientific Advisory Board To Drive Future Innovations

June 20, 2018

Lumicell Reports Positive Clinical Results with LUM System Demonstrating Rapid Identification of Residual Tumor in Lumpectomy Cavity of Patients with Breast Cancer

December 7, 2017

Lumicell Presents Phase 2 Clinical Data Showing LUM System Provided Complete and Immediate Detection of Residual Cancer in Tumor Cavity During Lumpectomy Surgery

December 7, 2017

Lumicell Expands Development Strategy and Pipeline Across Five Solid Tumor Cancers Supported by $28.7 Million Series C Financing

September 6, 2017

Lumicell Initiates New Clinical Studies in Breast Cancer and Prostate Cancer with LUM System for Real-time Detection of Tumor Tissue in Patients During Surgery

September 5, 2017

Lumicell to Participate in Upcoming Conferences

August 10, 2017

Lumicell Announces Product Development Progress with LUM015 in Lumicell System for Image-Guided Cancer Surgery

July 12, 2017

Lumicell Appoints Kelly Londy as Chief Executive Officer, Announces Additional Financing

June 28, 2017

Lumicell Appoints Felix Geissler, M.D., Ph.D. as Chief Medical Officer

August 9, 2016

Lumicell Awarded Direct Phase II Small Business Innovation Research (SBIR) Grant from the National Cancer Institute to Conduct Multi-Center Pivotal Study

April 13, 2016

Lumicell Successfully Completes Phase 2a Feasibility Study

January 6, 2016

Lumicell Publishes Data Supporting LUM015, Fluorescent Probe for Imaging Cancer, in Science Translational Medicine

September 10, 2015

Lumicell Announces FDA Approval to Launch Feasibility Study in Gastrointestinal Cancers

May 20, 2015

Lumicell Announces FDA Approval to Launch Feasibility Study

May 8, 2015

Lumicell Phase 1 Results Presented at SSO 2015 Annual Cancer Symposium

May 14, 2014

Lumicell Awarded SBIR Phase IIB Grant from National Science Foundation

August 7, 2013

Lumicell Awarded SBIR Grant from the National Cancer Institute

May 29, 2013

Lumicell Awarded with an Accelerator Loan from the Massachusetts Life Sciences Center